Ferrer, R, Zhu, N, Arranz, J, Porcel, I, El Bounasri, S, Sanchez, O, Torres, S, Julve, J, Lleo, A, Blanco-Vaca, F, Alcolea, D, Tondo, M. Importance of cerebrospinal fluid storage conditions for the Alzheimer's disease diagnostics on an automated platform. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(7)DOI:10.1515/cclm-2022-0134. PMID:35405043. IF:6.800(Q1/2D).

Moga, E, Lynton-Pons, E, Domingo, P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7.300(Q1/3D).

Castellano, MEM, Izquierdo, CP, Gonzalez, A, Llorente, AV, Ferreiras, DV, Sebastian, E, Candel, FG, Palao, HS, Segui, IG, de la Rubia, J, Cid, J, Nieto, JM, Mateo, LH, Viciedo, RG, Fidalgo, T, Salinas, R, Del Rio-Garma, J. Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura. MEDICINA CLINICA. 2022; 158(12)DOI:10.1016/j.medcli.2021.03.040. PMID:34266669. IF:3.900(Q2/4D).

Wanner, C, Fliser, D, Rychlik, I, Torra, R, Gansevoort, R, Ortiz, A, Sarafidis, P, Ong, A, Cozzolino, M, Rosenkranz, A, Tuglular, SZ, Gambaro, G, Fontana, M, Azzolini, L, Vinck, C. From WEDA to EDTA to ERA: 60 years of supporting European nephrology and counting. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(7)DOI:10.1093/ndt/gfac145. PMID:35389478. IF:6.100(Q1/2D).

Caravaca-Fontan, F, Diaz-Encarnacion, M, Cabello, V, Ariceta, G, Quintana, LF, Marco, H, Barros, X, Ramos, N, Rodriguez-Mendiola, N, Cruz, S, Fernandez-Juarez, G, Rodriguez, A, de Jose, AP, Rabasco, C, Rodado, R, Fernandez, L, Gomez, VP, Avila, A, Bravo, L, Espinosa, N, Allende, N, de la Nieta, MDS, Rodriguez, E, Olea, T, Melgosa, M, Huerta, A, Miquel, R, Mon, C, Fraga, G, de Lorenzo, A, Draibe, J, Cano-Megias, M, Gonzalez, F, Shabaka, A, Lopez-Rubio, ME, Fenollosa, MA, Martin-Penagos, L, Da Silva, I, Titos, JA, de Cordoba, SR, de Jorge, EG, Praga, M. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(7)DOI:10.1093/ndt/gfab075. PMID:33779754. IF:6.100(Q1/2D).

Brault, C, Mancebo, J, Montero, JCS, Bentall, T, Burns, KEA, Piraino, T, Lellouche, F, Bouchard, PA, Charbonney, E, Carteaux, G, Maraffi, T, Beduneau, G, Mercat, A, Skrobik, Y, Zuo, F, Lafreniere-Roula, M, Thorpe, K, Brochard, L, Bosma, KJ. The PROMIZING trial enrollment algorithm for early identification of patients ready for unassisted breathing. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-04063-4. PMID:35739553. IF:15.100(Q1/2D).

Ciruela P, Vilaró M, Carmona G, Jané M, Soldevila N, Garcia T, Hernández S, Ruiz L, Domínguez A, Rius C. Estimation of the incidence of invasive meningococcal disease using a capture-recapture model based on two independent surveillance systems in Catalonia, Spain.. BMJ Open. 2022; 12(6)DOI:10.1136/bmjopen-2021-058003. PMID:35728904. IF:2.900(Q2/5D).

Galan-Puchades, MT, Solano, J, Gonzalez, G, Osuna, A, Pascual, J, Bueno-Mari, R, Franco, S, Peracho, V, Montalvo, T, Fuentes, MV. Molecular detection of Leishmania infantum in rats and sand flies in the urban sewers of Barcelona, Spain. Parasites & Vectors. 2022; 15(1)DOI:10.1186/s13071-022-05309-4. PMID:35710435. IF:3.200(Q1/3D).

Gomez-Puerta, JA, Lobo-Prat, D, Perez-Garcia, C, Ponce, A, Frade-sosa, B, Arciniegas, AMM, Ojeda, F, Ruiz-Esquide, V, Corominas, H. Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.888377. PMID:35783644. IF:3.900(Q2/4D).

Chow, LQM, Barlesi, F, Bertino, EM, van den Bent, MJ, Wakelee, HA, Wen, PY, Chiu, CH, Orlov, S, Chiari, R, Majem, M, McKeage, M, Yu, CJ, Garrido, P, Hurtado, FK, Arratia, PC, Song, YB, Branle, F, Shi, M, Kim, DW. ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges. CLINICAL CANCER RESEARCH. 2022; 28(12)DOI:10.1158/1078-0432.CCR-21-1838. PMID:35091443. IF:11.500(Q1/1D).

Aranha, MR, Fortea, J, Carmona-Iragui, M. Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease. NEUROLOGY. 2022; 98(24)DOI:10.1212/WNL.0000000000200704. PMID:35470138. IF:9.900(Q1/1D).

Crea, F, Badimon, L, Berry, C, De Caterina, R, Elliott, PM, Hatala, R, Libby, P, Linde, C, Tybjaerg-Hansen, A. The European Heart Journal: fulfilling the mission. EUROPEAN HEART JOURNAL. 2022; 43(23)DOI:10.1093/eurheartj/ehac171. PMID:35512309. IF:39.300(Q1/1D).

Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.829490. PMID:35757319. IF:3.600(Q2/5D).

Perl, AE, Larson, RA, Podoltsev, NA, Strickland, S, Wang, ES, Atallah, E, Schiller, GJ, Martinelli, G, Neubauer, A, Sierra, J, Montesinos, P, Recher, C, Yoon, SS, Hosono, N, Onozawa, M, Chiba, S, Kim, HJ, Hasabou, N, Lu, QY, Tiu, R, Levis, MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. BLOOD. 2022; 139(23)DOI:10.1182/blood.2021011583. PMID:35081255. IF:20.300(Q1/1D).

Kaivola, K, Shah, Z, Chia, R, Scholz, SW, Alcolea, D., Clarimón, J., Fortea, J., Lleó, A., Int LBD Genomics Consortium. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. BRAIN. 2022; 145(5)DOI:10.1093/brain/awab402. PMID:35381062. IF:14.500(Q1/1D).

Rivera, CM, Crespo-Lessman, A, Arismendi, E, Munoz-Esquerre, M, Aguilar, X, Ausin, P, Bobolea, I, Duch, GD, Teixido, RP, Talaverano, GS, Sabardia, AS, Gall, XM. Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis. JOURNAL OF ASTHMA. 2022; 59(6)DOI:10.1080/02770903.2021.1917605. PMID:33882776. IF:1.900(Q4/8D).

Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Aracil-Bolanos, I, Horta-Barba, A, Puig-Davi, A, Pagonabarraga, J. A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.866502. PMID:35720066. IF:3.400(Q2/5D).

Tam, CS, Allan, JN, Siddiqi, T, Kipps, TJ, Jacobs, R, Opat, S, Barr, PM, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, BJ, Moreno, C, Szafer-Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, JP, Wierda, WG, Ghia, P. Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort. BLOOD. 2022; 139(22)DOI:10.1182/blood.2021014488. PMID:35196370. IF:20.300(Q1/1D).

Carrasco-Rozas, A, Fernandez-Simon, E, Lleixa, MC, Belmonte, I, Pedrosa-Hernandez, I, Montiel-Morillo, E, Nunez-Peralta, C, Rossello, JL, Segovia, S, De Luna, N, Suarez-Calvet, X, Illa, I, Diaz-Manera, J, Gallardo, E, Barba-Romero, MA, Barcena, J, Carzorla, MR, Creus, C, Coll-Canti, J, Diaz, M, Dominguez, C, Torron, RF, Antelo, MJG, Grau, JM, Caravaca, MTG, Hernandez, JCL, de Munain, AL, Martinez-Garcia, FA, Morgado, Y, Moreno, A, Moris, G, Munoz-Blanco, MA, Nascimento, A, Paradas, C, Pozo, JLP, Querol, L, Robledo-Strauss, A, Garcia, RR, Rojas-Marcos, I, Salazar, JA, Uson, M. Identification of serum microRNAs as potential biomarkers in Pompe disease (vol 6, pg 1214, 2019). Annals of Clinical and Translational Neurology. 2022; 9(6)DOI:10.1002/acn3.51600. PMID:31353854. IF:5.300(Q1/2D).

Liberatore, G, De Lorenzo, A, Giannotta, C, Manganelli, F, Filosto, M, Cosentino, G, Cocito, D, Briani, C, Cortese, A, Fazio, R, Lauria, G, Clerici, AM, Rosso, T, Marfia, GA, Antonini, G, Cavaletti, G, Carpo, M, Doneddu, PE, Spina, E, Piccinelli, SC, Peci, E, Querol, L, Nobile-Orazio, E. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database. NEUROLOGICAL SCIENCES. 2022; 43(6)DOI:10.1007/s10072-021-05811-0. PMID:35048233. IF:3.300(Q2/5D).